Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
44.68
+1.63 (3.79%)
At close: Jul 19, 2024, 4:00 PM
44.70
+0.02 (0.04%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Janux Therapeutics stock have an average target of 64.63, with a low estimate of 47 and a high estimate of 100. The average target predicts an increase of 44.65% from the current stock price of 44.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for JANX stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 3 | 4 | 4 | 4 | 4 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 6 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Hold Initiates $47 | Hold | Initiates | $47 | +5.19% | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $63 | Strong Buy | Maintains | $50 → $63 | +41.00% | May 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +123.81% | May 9, 2024 |
| Wedbush | Wedbush | Buy Maintains $53 → $74 | Buy | Maintains | $53 → $74 | +65.62% | May 8, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +56.67% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
3.79M
from 8.08M
Decreased by -53.07%
Revenue Next Year
2.79M
from 3.79M
Decreased by -26.50%
EPS This Year
-1.34
from -1.32
EPS Next Year
-1.70
from -1.34
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.5M | 8.7M | 52.5M | 26.3M | 294.0M |
| Avg | 3.8M | 2.8M | 12.1M | 11.6M | 133.8M |
| Low | 1.2M | n/a | n/a | n/a | 4.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.2% | 129.8% | 1,783.1% | 117.8% | 2,428.2% |
| Avg | -53.1% | -26.5% | 332.3% | -3.5% | 1,050.6% |
| Low | -84.8% | - | - | - | -57.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.86 | -0.96 | -1.35 | -1.66 | -0.97 |
| Avg | -1.34 | -1.70 | -1.95 | -2.79 | -2.30 |
| Low | -1.52 | -2.68 | -2.70 | -3.65 | -3.85 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.